Kriya Therapeutics Stock

kriyatherapeutics.comHealthcareFounded: 2019Funding to Date: $458.18MM

Kriya Therapeutics is a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy.

Register for Details

For more details on financing and valuation for Kriya Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Kriya Therapeutics.

Register Today

Kriya Therapeutics investors also invested in these private companies

Patient Square Capital
QVT Financial LP
Dexcel Pharma
Woodline Partners
Cam Capital
Bluebird Ventures

Team

Management Team

Shankar Ramaswamy, MD
Co-Founder & Chief Executive Officer
Nachi Gupta, MD, PhD
President, Technology
Melissa Rhodes, PhD, DABT
President, Research and Development
Neera Ravindran, MD
Chief Financial Officer
Ilise Lombardo, MD
President
Michele Stone, PhD
Chief Scientific Officer

Board Members

Jim Momtazee
Patient Square Capital
CR Sincock II
Transhuman Capital
Saira Ramasastry
Life Sciences Advisory
Roger Jeffs, PhD
Kriya Therapeutics
Neel Varshney, MD
Patient Square Capital
Keith Manchester, MD
Life Sciences for QVT Family Office

Other companies like Kriya Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM